217 related articles for article (PubMed ID: 11471390)
1. [Inhaled nitric oxide: therapeutic applications in cardiac surgery].
Estanove S; Girard C; Bastien O; Piriou V; Lehot JJ
Bull Acad Natl Med; 2000; 184(8):1715-26; discussion 1727-9. PubMed ID: 11471390
[TBL] [Abstract][Full Text] [Related]
2. Inhaled prostacyclin, nitric oxide, and nitroprusside in pulmonary hypertension after mitral valve replacement.
Fattouch K; Sbraga F; Bianco G; Speziale G; Gucciardo M; Sampognaro R; Ruvolo G
J Card Surg; 2005; 20(2):171-6. PubMed ID: 15725144
[TBL] [Abstract][Full Text] [Related]
3. [Pulmonary hypertension: the role of nitric oxide in adults].
Neidecker J
Rev Esp Anestesiol Reanim; 2001 Dec; 48(10):457-9. PubMed ID: 11792299
[TBL] [Abstract][Full Text] [Related]
4. Inhaled epoprostenol for the treatment of pulmonary arterial hypertension in critically ill adults.
Buckley MS; Feldman JP
Pharmacotherapy; 2010 Jul; 30(7):728-40. PubMed ID: 20575636
[TBL] [Abstract][Full Text] [Related]
5. Hemodynamic effects of inhaled nitric oxide and phosphodiesterase inhibitor (dipyridamole) on secondary pulmonary hypertension following heart valve surgery in adults.
Santini F; Casali G; Franchi G; Auriemma S; Lusini M; Barozzi L; Favaro A; Messina A; Mazzucco A
Int J Cardiol; 2005 Aug; 103(2):156-63. PubMed ID: 16080974
[TBL] [Abstract][Full Text] [Related]
6. Use of sildenafil to facilitate weaning from inhaled nitric oxide in children with pulmonary hypertension following surgery for congenital heart disease.
Lee JE; Hillier SC; Knoderer CA
J Intensive Care Med; 2008; 23(5):329-34. PubMed ID: 18701525
[TBL] [Abstract][Full Text] [Related]
7. [Inhalation nitric oxide during heart transplantation].
Kozlov IA; Poptsov VN
Anesteziol Reanimatol; 1999; (5):9-14. PubMed ID: 10560143
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and safety of intravenously administered citrulline in children undergoing congenital heart surgery: potential therapy for postoperative pulmonary hypertension.
Barr FE; Tirona RG; Taylor MB; Rice G; Arnold J; Cunningham G; Smith HA; Campbell A; Canter JA; Christian KG; Drinkwater DC; Scholl F; Kavanaugh-McHugh A; Summar ML
J Thorac Cardiovasc Surg; 2007 Aug; 134(2):319-26. PubMed ID: 17662768
[TBL] [Abstract][Full Text] [Related]
9. Peri-operative pulmonary hypertension in paediatric patients: current strategies in children with congenital heart disease.
Gorenflo M; Gu H; Xu Z
Cardiology; 2010; 116(1):10-7. PubMed ID: 20424447
[TBL] [Abstract][Full Text] [Related]
10. Variable response to inhaled nitric oxide in postoperative patients of mitral stenosis with pulmonary hypertension.
Razzaq Z; Aslam M; Hussain MM; Naqvi S; Zameer M; Badar A
J Ayub Med Coll Abbottabad; 2009; 21(1):98-102. PubMed ID: 20364753
[TBL] [Abstract][Full Text] [Related]
11. Does inhaled nitric oxide improve survival in operated congenital disease with severe pulmonary hypertension?
Sharma R; Raizada N; Choudhary SK; Bhan A; Kumar P; Juneja R; Kothari SS; Saxena A; Venugopal P
Indian Heart J; 2001; 53(1):48-55. PubMed ID: 11456141
[TBL] [Abstract][Full Text] [Related]
12. Inhaled prostacyclin following surgical repair of congenital heart disease--a pilot study.
Carroll CL; Backer CL; Mavroudis C; Cook K; Goodman DM
J Card Surg; 2005; 20(5):436-9. PubMed ID: 16153274
[TBL] [Abstract][Full Text] [Related]
13. [Effectiveness of adenosine as a pulmonary vasodilator during weaning from extracorporeal circulation after mitral valve replacement in a patient with severe pulmonary hypertension].
Charco Mora P; Cantó Pastor M; García Escobar M
Rev Esp Anestesiol Reanim; 1999 May; 46(5):223-5. PubMed ID: 10379190
[TBL] [Abstract][Full Text] [Related]
14. A prospective, randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients.
Khan TA; Schnickel G; Ross D; Bastani S; Laks H; Esmailian F; Marelli D; Beygui R; Shemin R; Watson L; Vartapetian I; Ardehali A
J Thorac Cardiovasc Surg; 2009 Dec; 138(6):1417-24. PubMed ID: 19931670
[TBL] [Abstract][Full Text] [Related]
15. Early postoperative care of patients with pulmonary hypertension associated with congenital cardiac disease.
Adatia I; Beghetti M
Cardiol Young; 2009 Aug; 19(4):315-9. PubMed ID: 19493364
[No Abstract] [Full Text] [Related]
16. Inhaled nitric oxide through a noninvasive ventilation device to assess reversibility of pulmonary hypertension in selecting recipients for heart transplant.
Fojón S; Fernández-González C; Sánchez-Andrade J; López-Pérez JM; Hermida LF; Rodríguez JA; Juffé A
Transplant Proc; 2005 Nov; 37(9):4028-30. PubMed ID: 16386617
[TBL] [Abstract][Full Text] [Related]
17. Use of sildenafil with inhaled nitric oxide in the management of severe pulmonary hypertension.
Saygili A; Canter B; Iriz E; Kula S; Tunaoğlu FS; Olguntürk R; Ozdoğan ME
J Cardiothorac Vasc Anesth; 2004 Dec; 18(6):775-6. PubMed ID: 15650993
[No Abstract] [Full Text] [Related]
18. Soluble guanylate cyclase activator reverses acute pulmonary hypertension and augments the pulmonary vasodilator response to inhaled nitric oxide in awake lambs.
Evgenov OV; Ichinose F; Evgenov NV; Gnoth MJ; Falkowski GE; Chang Y; Bloch KD; Zapol WM
Circulation; 2004 Oct; 110(15):2253-9. PubMed ID: 15466650
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the usage of intravenous iloprost and nitroglycerin for pulmonary hypertension during valvular heart surgery.
Baysal A; Bilsel S; Bulbul OG; Kayacioglu I; Idiz M; Yekeler I
Heart Surg Forum; 2006; 9(1):E536-42. PubMed ID: 16387672
[TBL] [Abstract][Full Text] [Related]
20. Management of adult patients with perioperative pulmonary hypertension: technical aspects and therapeutic options.
Winterhalter M; Antoniou T; Loukanov T
Cardiology; 2010; 116(1):3-9. PubMed ID: 20424446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
